RxDoctor Payments DataLook up a doctor →

Kevin Windsor

Hematology & Oncology · Birmingham, ALNPI 1801828405

Payments from drug & device makers

$108,517in general payments, 2019–2025

Across 570 payments — averaging $190.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$96K
  • Genentech USA, Inc.$2K
  • Bristol Myers Squibb$1K
  • Rigel Pharmaceuticals, Inc.$1K
  • Amgen$1K
  • Merck$643
  • plus $6K from 53 others

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.35$96,178
Genentech USA, Inc.26$2,191
Bristol Myers Squibb17$1,122
Rigel Pharmaceuticals, Inc.4$1,043
Amgen52$1,019
Merck41$643
AstraZeneca(2 entities)39$595
Novartis31$567
Seagen Inc.31$465
Johnson & Johnson(2 entities)27$443
Takeda Pharmaceuticals U.S.A., Inc.32$440
Pfizer21$277
Eisai Inc.15$270
Incyte Corporation13$240
Pharmacyclics LLC, An Abbvie Company16$236
Daiichi Sankyo Inc.14$227
Exelixis Inc.14$221
AbbVie9$179
Gilead(2 entities)11$159
Lilly USA, LLC13$156
Bayer9$150
GSK8$125
Boehringer Ingelheim5$109
Sanofi5$99
Epizyme, Inc.5$91
Regeneron Healthcare Solutions, Inc.5$85
Deciphera Pharmaceuticals Inc.4$85
Puma Biotechnology, Inc.4$63
Array Biopharma Inc4$62
Kyowa Kirin, Inc.4$60
Astellas Pharma US Inc4$58
Dova Pharmaceuticals3$57
Blueprint Medicines Corporation3$52
Beigene USA, Inc.3$50
Karyopharm Therapeutics Inc.3$50
Taiho Oncology, Inc.3$47
Octapharma USA, Inc.2$46
Helsinn Therapeutics (U.S.), Inc.3$44
Ipsen Biopharmaceuticals, Inc2$42
Pharmacosmos Therapeutics Inc.2$40
Sobi, Inc1$38
AVEO Pharmaceuticals, Inc.2$35
Acrotech Biopharma Inc.2$32
Myriad Genetic Laboratories, Inc.2$31
EMD Serono, Inc.2$29
Myovant Sciences Inc.2$28
Morphosys, US Inc.2$28
Boston Scientific2$28
Tesaro, Inc.1$25
Shire North American Group Inc1$18
Clovis Oncology, Inc.3$18
Adaptive Biotechnologies Corporation1$18
Novocure Inc.1$17
Jazz Pharmaceuticals Inc.1$16
Verastem, Inc.1$16
AMAG Pharmaceuticals, Inc.1$14
Sandoz1$14
Lexicon Pharmaceuticals, Inc.1$13
TG Therapeutics, Inc.1$12

How this compares

$108,517 in reported general payments places this provider in the 70th percentile of 177 hematology & oncology providers in Alabama.

See all hematology & oncology providers in Alabama →

Other hematology & oncology in Birmingham

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →